2024
-
May 10, 2024 Management & Finance
Outline of Consolidated Financial Results for the Year Ended March 31, 2024
-
April 16, 2024 R & D PDF282 KB
-
April 04, 2024 R & D PDF266 KB
Announcement of Research Alliance with MiNA Therapeutics in the Field of Central Nervous System
-
March 26, 2024 Pharmaceuticals PDF297 KB
Vyxeos® Combination for I.V. Injection Receives Approval for the Treatment of High-risk AML in Japan
-
March 26, 2024 Pharmaceuticals PDF303 KB
-
March 25, 2024 R & D PDF279 KB
-
March 06, 2024 R & D PDF262 KB
-
February 27, 2024 R & D PDF252 KB
-
February 09, 2024 R & D PDF239 KB
-
February 09, 2024 Management & Finance
Outline of Consolidated Financial Results for the Third Quarter Ended December 31, 2023
-
January 22, 2024 R & D PDF263 KB